US Stock MarketDetailed Quotes

Immix Biopharma (IMMX)

Watchlist
  • 8.750
  • -0.340-3.74%
Close Apr 8 16:00 ET
  • 8.750
  • 0.0000.00%
Post 16:10 ET
463.86MMarket Cap-9.83P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immix Biopharma (IMMX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
32.11%29.96M
118.43%10.89M
3.62%7.66M
42.85%6.72M
-16.23%4.68M
40.48%22.67M
-7.23%4.99M
63.47%7.39M
26.39%4.7M
121.76%5.59M
Selling and administrative expenses
20.35%13.7M
43.00%5.17M
4.37%3.08M
10.77%2.75M
15.65%2.71M
53.68%11.38M
58.80%3.61M
21.99%2.95M
63.97%2.48M
94.84%2.34M
-General and administrative expense
20.35%13.7M
43.00%5.17M
4.37%3.08M
10.77%2.75M
15.65%2.71M
53.68%11.38M
58.80%3.61M
21.99%2.95M
63.97%2.48M
94.84%2.34M
Research and development costs
43.97%16.26M
316.70%5.73M
3.12%4.58M
78.61%3.97M
-39.20%1.98M
29.28%11.29M
-55.68%1.37M
111.09%4.45M
0.67%2.22M
146.29%3.25M
Operating profit
-32.11%-29.96M
-118.43%-10.89M
-3.62%-7.66M
-42.85%-6.72M
16.23%-4.68M
-40.48%-22.67M
7.23%-4.99M
-63.47%-7.39M
-26.39%-4.7M
-121.76%-5.59M
Net non-operating interest income expense
-45.40%555.53K
16.61%216.71K
-67.06%84.54K
-66.10%104.06K
-43.93%150.22K
77.86%1.02M
-18.69%185.85K
37.49%256.68K
138.20%306.92K
860.52%267.91K
Non-operating interest income
-45.40%555.53K
16.61%216.71K
-67.06%84.54K
-66.10%104.06K
-43.93%150.22K
77.86%1.02M
-18.69%185.85K
37.49%256.68K
138.20%306.92K
860.52%267.91K
Other net income (expense)
Income before tax
-35.75%-29.4M
-122.37%-10.68M
-6.16%-7.58M
-50.46%-6.61M
14.83%-4.53M
-39.10%-21.66M
6.72%-4.8M
-64.59%-7.14M
-22.38%-4.4M
-113.50%-5.32M
Income tax
-8.07%37.72K
4.46%11.27K
-30.71%7.72K
-13.20%8.91K
11.12%9.82K
55.35%41.04K
33.33%10.79K
63.71%11.14K
61.74%10.27K
70.97%8.84K
Net income
-35.67%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
Net income continuous Operations
-35.67%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
Minority interest income
0
0
0
0
0
49.85%-84.99K
0
0
41.29%-12.91K
-292.38%-72.07K
Net income attributable to the parent company
-36.21%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
-40.11%-21.61M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.21%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
-40.11%-21.61M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
Basic earnings per share
-17.11%-0.89
-75.00%-0.28
0.00%-0.24
-46.67%-0.22
31.82%-0.15
14.61%-0.76
33.33%-0.16
-4.35%-0.24
37.50%-0.15
-22.22%-0.22
Diluted earnings per share
-17.11%-0.89
-75.00%-0.28
0.00%-0.24
-46.67%-0.22
31.82%-0.15
14.61%-0.76
33.33%-0.16
-4.35%-0.24
37.50%-0.15
-22.22%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 32.11%29.96M118.43%10.89M3.62%7.66M42.85%6.72M-16.23%4.68M40.48%22.67M-7.23%4.99M63.47%7.39M26.39%4.7M121.76%5.59M
Selling and administrative expenses 20.35%13.7M43.00%5.17M4.37%3.08M10.77%2.75M15.65%2.71M53.68%11.38M58.80%3.61M21.99%2.95M63.97%2.48M94.84%2.34M
-General and administrative expense 20.35%13.7M43.00%5.17M4.37%3.08M10.77%2.75M15.65%2.71M53.68%11.38M58.80%3.61M21.99%2.95M63.97%2.48M94.84%2.34M
Research and development costs 43.97%16.26M316.70%5.73M3.12%4.58M78.61%3.97M-39.20%1.98M29.28%11.29M-55.68%1.37M111.09%4.45M0.67%2.22M146.29%3.25M
Operating profit -32.11%-29.96M-118.43%-10.89M-3.62%-7.66M-42.85%-6.72M16.23%-4.68M-40.48%-22.67M7.23%-4.99M-63.47%-7.39M-26.39%-4.7M-121.76%-5.59M
Net non-operating interest income expense -45.40%555.53K16.61%216.71K-67.06%84.54K-66.10%104.06K-43.93%150.22K77.86%1.02M-18.69%185.85K37.49%256.68K138.20%306.92K860.52%267.91K
Non-operating interest income -45.40%555.53K16.61%216.71K-67.06%84.54K-66.10%104.06K-43.93%150.22K77.86%1.02M-18.69%185.85K37.49%256.68K138.20%306.92K860.52%267.91K
Other net income (expense)
Income before tax -35.75%-29.4M-122.37%-10.68M-6.16%-7.58M-50.46%-6.61M14.83%-4.53M-39.10%-21.66M6.72%-4.8M-64.59%-7.14M-22.38%-4.4M-113.50%-5.32M
Income tax -8.07%37.72K4.46%11.27K-30.71%7.72K-13.20%8.91K11.12%9.82K55.35%41.04K33.33%10.79K63.71%11.14K61.74%10.27K70.97%8.84K
Net income -35.67%-29.44M-122.11%-10.69M-6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M-113.41%-5.33M
Net income continuous Operations -35.67%-29.44M-122.11%-10.69M-6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M-113.41%-5.33M
Minority interest income 0000049.85%-84.99K0041.29%-12.91K-292.38%-72.07K
Net income attributable to the parent company -36.21%-29.44M-122.11%-10.69M-6.10%-7.59M-50.75%-6.62M13.62%-4.54M-40.11%-21.61M5.45%-4.81M-67.02%-7.15M-22.84%-4.39M-112.08%-5.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.21%-29.44M-122.11%-10.69M-6.10%-7.59M-50.75%-6.62M13.62%-4.54M-40.11%-21.61M5.45%-4.81M-67.02%-7.15M-22.84%-4.39M-112.08%-5.26M
Basic earnings per share -17.11%-0.89-75.00%-0.280.00%-0.24-46.67%-0.2231.82%-0.1514.61%-0.7633.33%-0.16-4.35%-0.2437.50%-0.15-22.22%-0.22
Diluted earnings per share -17.11%-0.89-75.00%-0.280.00%-0.24-46.67%-0.2231.82%-0.1514.61%-0.7633.33%-0.16-4.35%-0.2437.50%-0.15-22.22%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -